VEOPOZ Trademark

Trademark Overview

On Tuesday, March 8, 2022, a trademark application was filed for VEOPOZ with the United States Patent and Trademark Office. The USPTO has given the VEOPOZ trademark a serial number of 97301520. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, August 28, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The VEOPOZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological and neuromuscular diseases and disorders
veopoz

General Information

Serial Number97301520
Word MarkVEOPOZ
Filing DateTuesday, March 8, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, August 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hematological and neuromuscular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Friday, March 11, 2022NEW APPLICATION ENTERED
Monday, March 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 19, 2022ASSIGNED TO EXAMINER
Wednesday, December 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 23, 2023SOU EXTENSION 1 FILED
Wednesday, August 23, 2023SOU EXTENSION 1 GRANTED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 30, 2023TEAS REQUEST TO DIVIDE RECEIVED
Monday, October 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 30, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, November 1, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, November 2, 2023CORRECTED NOA E-MAILED
Tuesday, March 19, 2024SOU EXTENSION 2 FILED
Tuesday, March 19, 2024SOU EXTENSION 2 GRANTED
Tuesday, March 19, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 28, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 28, 2024SOU EXTENSION 3 FILED
Wednesday, August 28, 2024SOU EXTENSION 3 GRANTED

Related Keywords

veopoz diseases disorders neuromuscular hematological preparations treatment pharmaceutical